Pfizer Inc.

General ticker "PFE" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $146.8B (TTM average)

Pfizer Inc. follows the US Stock Market performance with the rate: 16.1%.

Estimated limits based on current volatility of 0.9%: low 27.24$, high 27.70$

Factors to consider:

  • Company included in S&P500 list
  • Company pays dividends (quarterly): last record date 2026-07-24, amount 0.43$ (Y6.26%)
  • Total employees count: 75000 (-7.4%) as of 2025
  • US accounted for 60.8% of revenue in the fiscal year ended 2024-12-31
  • Top business risk factors: Product development failure, Regulatory and compliance, Supply chain disruptions, IP infringement, Geopolitical risks
  • Price in estimated range
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [20.90$, 30.63$]
  • 2026-12-31 to 2027-12-31 estimated range: [23.51$, 33.78$]

Financial Metrics affecting the PFE estimates:

  • Positive: with PPE of 7.7 at the end of fiscal year the price was neutral
  • Positive: 6.77 < Operating cash flow per share per price, % of 8.23
  • Positive: 22.58 < Operating profit margin, % of 24.67
  • Positive: Inventory ratio change, % of 0.82 <= 1.34
  • Positive: 34.41 < Shareholder equity ratio, % of 41.54 <= 42.26
  • Positive: Industry inventory ratio change (median), % of 0.50 <= 1.15
  • Positive: Interest expense per share per price, % of 1.88 <= 2.54
  • Positive: 3.48 < Return on assets ratio (scaled to [-100,100]) of 3.60
  • Negative: Investing cash flow per share per price, % of -0.95 <= -0.14

Similar symbols

Short-term PFE quotes

Relationship graph

Long-term PFE plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $59,332.00MM $63,627.00MM $62,579.00MM
Operating Expenses $58,274.00MM $47,144.00MM $47,142.00MM
Operating Income $1,058.00MM $16,483.00MM $15,437.00MM
Non-Operating Income $0.00MM $-8,460.00MM $-7,917.00MM
Interest Expense $2,209.00MM $3,091.00MM $2,671.00MM
R&D Expense $10,578.00MM $10,738.00MM $11,976.00MM
Income(Loss) $1,058.00MM $8,023.00MM $7,520.00MM
Taxes $-1,115.00MM $-28.00MM $-266.00MM
Other Income(Loss) $-14.00MM $11.00MM $25.00MM
Net Income(Loss)* $2,119.00MM $8,020.00MM $7,770.00MM
Stockholders Equity $89,014.00MM $88,203.00MM $86,476.00MM
Inventory $10,189.00MM $10,851.00MM $10,654.00MM
Assets $226,501.00MM $213,396.00MM $208,160.00MM
Operating Cash Flow $8,700.00MM $12,744.00MM $11,705.00MM
Capital expenditure $3,907.00MM $2,909.00MM $2,629.00MM
Investing Cash Flow $-32,278.00MM $2,652.00MM $-1,351.00MM
Financing Cash Flow $26,066.00MM $-17,140.00MM $-10,304.00MM
Earnings Per Share** $0.38 $1.42 $1.37

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.